| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.0001 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.16 | 0.0002 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0005 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0006 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.22 | 0.0006 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0007 |